Literature DB >> 29128837

The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles.

Jing Cao1, Yahui Zhang1, Yukun Wu1, Jing Wu1, Wei Wang1, Qiang Wu1, Zhi Yuan2.   

Abstract

It has been shown that multivalent ligands could significantly enhance the binding avidity compared with the monovalent ones; therefore, once incorporated into nanoparticles, they promote superior targeting ability without increasing the ligand density. Although ligand valency and density play a key role on the targeting ability of corresponding nanoparticles, these facotrs remain largely unexplored and detailed studies are lacking. Herein, a series of multivalent ligands with certain valencies (FAn, n indicates the valency of ligand: n=3, 5, 7) has been conveniently synthesized by conjugating different copies of folate ligands with poly(acrylic acid) (PAA). Negatively charged chitosan nanoparticles (CTS-SA NPs) have been utilized as proper multivalent platforms because they can strongly suppress non-specific protein adsorption and cellular uptake without interfering with the targeting ability of multivalent ligands. Subsequently, the structure of CTS-SA NPs has been modified using different amounts of FAn to form multivalent nanoparticles (FAn-CTS-SA NPs) with various valencies and densities. A series of specific investigations of them suggested that the cellular uptake of multivalent nanoparticles has largely varied with the ligand valency variation even at similar ligand densities; and also largely varied with ligand density variation even at the same ligand valencies. The intermediate valency and density values determined in the current study (ie., 5 and 2.4wt%, respectively) have provided the best cellular uptake, facilitating superior targeting ability at relatively low ligand valency and density. Unexpectedly, no conspicuous difference has been observed during endocytotic inhibition assays with single inhibitors, which may be attributed to the synergetic endocytotic mechanism with multiple pathways of multivalent nanoparticles. The optimal multivalent nanoparticles have also exhibited excellent biocompatibility, long-term stability in vitro and enhanced circulation time in vivo, thus demonstrating their potential for targeted drug delivery.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Folate; Ligand density; Ligand valency; Multivalent nanoparticles; Targeting ability

Mesh:

Substances:

Year:  2017        PMID: 29128837     DOI: 10.1016/j.colsurfb.2017.11.015

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer Nanoparticles.

Authors:  Marian A Ackun-Farmmer; Kharimat L Alatise; Griffin Cross; Danielle S W Benoit
Journal:  Adv Biosyst       Date:  2020-10-19

2.  Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better.

Authors:  Huimin Li; Jiaxing Di; Baowei Peng; Yuhong Xu; Ning Zhang
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

Review 3.  Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy.

Authors:  Xiaoqiu Xu; Tong Li; Ke Jin
Journal:  Pharmaceutics       Date:  2022-05-23       Impact factor: 6.525

Review 4.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

5.  Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type.

Authors:  Nikša Roki; Melani Solomon; Jessica Bowers; Lori Getts; Robert C Getts; Silvia Muro
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.